Table 1.
Demographic and disease characteristics at baseline
| CA group (n = 41/lesion = 42) | AHC group (n = 40/lesion = 41) | P‐value | |
|---|---|---|---|
| Age‐year (mean ± SD) | 62.49 ± 9.74 | 64.73 ± 8.95 | 0.285 |
| Sex n (%) | 0.678 | ||
| Male | 28 (68.3%) | 29 (72.5%) | |
| Female | 13 (31.7%) | 11 (27.5%) | |
| Tumor location n (%) | 0.086 | ||
| Central | 20 (47.6%) | 12 (29.3%) | |
| Peripheral | 22 (52.4%) | 29 (70.7%) | |
| Pathology n (%) | 1.000 | ||
| Squamous | 11 (26.2%) | 12 (29.3%) | |
| Adenocarcinoma | 29 (69%) | 28 (68.3%) | |
| Large cell carcinoma | 1 (2.4%) | 0 (0%) | |
| Unknown | 1 (2.4%) | 1 (2.4%) | |
| Stage n (%) | 0.605 | ||
| IIIa | 7 (17.1%) | 11 (27.5%) | |
| IIIb | 7 (17.1%) | 7 (17.5%) | |
| IV | 26 (63.4%) | 22 (55%) | |
| NA | 1 (2.4%) | 0 (0%) | |
| Pulmonary resection history n (%) | 0.928 | ||
| Yes | 16 (39.0%) | 16 (40.0%) | |
| No | 25 (61.0%) | 24 (60.0%) | |
| Radiotherapy or chemotherapy history n (%) | 0.107 | ||
| Yes | 16 (39.0%) | 9 (22.5%) | |
| No | 25 (61.0%) | 31 (77.5%) | |
| Cardiovascular or pulmonary risk n (%) | 0.141 | ||
| Yes | 20 (48.8%) | 26 (65%) | |
| No | 21 (51.2%) | 14 (35%) | |
| Long axis of lesion cm (mean ± SD) | 4.01 ± 0.96 | 4.00 ± 1.10 | 0.966 |
| Short axis of lesion cm (mean ± SD) | 3.25 ± 1.17 | 3.22 ± 1.05 | 0.909 |
|
Largest area of the lesion cm2 (mean ± SD) |
14.34 ± 7.24 | 13.99 ± 7.87 | 0.835 |